Henrietta Fore - Director, Theravance Biopharma, Inc

As of August 11, 2017


Henrietta Fore Net Worth

  • Net worth is estimated to be at least $5.35M
  • Owns at least 24,000 units of Theravance Biopharma, Inc stock

Henrietta Fore Trading

  • Largest purchase of shares was 6,000 units , worth over $143.93K on August 11, 2017
  • In total has made about 5 transactions over 3 years
  • Usually trades in May, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Henrietta Fore Mailing Address

  • Mailing address is Theravance, Inc. 901 Gateway Blvd. South San Francisco CA 94080 CA

Theravance Biopharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Rick E Winningham 2020 $1,014,455 - $579,646 - $579,646 $6,045 $6,577,746
Rick E Winningham 2019 $983,710 - $473,906 - $473,906 $5,496 $5,932,411
Rick E Winningham 2018 $956,600 $74,767 $690,154 - $690,154 $5,000 $2,522,841
Andrew A. Hindman 2020 $551,608 - $265,278 - $265,278 $5,920 $2,097,950
Andrew A. Hindman 2019 $315,000 $175,000 $216,000 $2,204,956 $216,000 - $3,757,956
Brett Haumann 2020 $572,569 - $213,589 - $213,589 $53,267 $2,742,625
Brett Haumann 2019 $543,047 - $170,000 - $170,000 $42,382 $2,464,280
Brett Haumann 2018 $497,810 $34,125 $315,000 - $315,000 $414,300 $1,517,194
Vijay Sabesan 2020 $407,677 - $760,326 - $760,326 $6,541 $3,077,744
Bradford J. Shafer 2020 $556,321 - $264,999 - $264,999 $6,045 $2,730,565
Bradford J. Shafer 2019 $537,403 - $215,611 - $215,611 $6,983 $2,468,848
Bradford J. Shafer 2018 $518,080 $33,770 $311,726 - $311,726 $5,000 $1,124,537
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1583107/000110465921039784/tm212357-1_def14a.htm

Theravance Biopharma, Inc Insider Trading

  • The most recent transaction was 3,281 units sold on May 24, 2022 by Rhonda Farnum worth over $28.88K
  • In the last 7 years, insiders at Theravance Biopharma, Inc sold an estimated value of $52.4M and bought an estimated value of $26.3M
  • The most active traders are Bradford Shafer, EVP,  Rick Winningham, CHIEF EXECUTIVE OFFICER,  and Philip Worboys, SVP
  • Insider trading is most common in February, with the busiest year in 2018

Theravance Biopharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1